A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is application/pdf
.
The effects of CES1A2 and CYP2C19 polymorphisms on responsiveness to clopidogrel and clinical outcomes among Chinese patients with acute ischemic stroke
2017
Int J Clin Exp Med
unpublished
Little research about genotype and clopidogrel response related to acute ischemic stroke has been published. The study evaluated the gene polymorphisms involved in the metabolic process affecting clopidogrel response and acute ischemic stroke clinical outcomes. We evaluated 191 non-cardioembolic ischemic stroke (NCIS) patients treated with clopidogrel. The platelet reactivity with clopidogrel treatment for 5 days was measured using thrombelastography platelet mapping assay. CES1A2 A (-816) C
fatcat:e2kbfqymtzarrjjg3okrfjm3fu